1.3%; aOR, 0.601; 95% CI, 0.350–1.031; P = 0.065) had a borderline significance.
← all excerpts
Impact of Palivizumab in Preventing Severe Acute Lower Respiratory Infection in Moderate-to-Late Preterm Infants: A Nationwide Cohort Study.
1
—
—
1.3%; aOR, 0.601; 95% CI, 0.350–1.031; P = 0.065) had a borderline significance.